NCT06778408View on ClinicalTrials.gov

Hybrid Arc Palliative Radiation Therapy (HART): a Single Arm Phase II Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

March 31, 2028

Conditions
Palliative RadiotherapyMetastatic Cancer (different Solid Tumour Types)
Interventions
RADIATION

Hybrid Palliative Radiation Therapy

Hybrid Palliative Radiation Therapy will be administered to all patients.

Trial Locations (1)

05401

University of Vermont Medical Center, Burlington

All Listed Sponsors
lead

University of Vermont Medical Center

OTHER